✦ LIBER ✦

HAC-cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating Chemotherapy With Intensification

✍ Scribed by Morton Coleman; Mark W. Pasmantier; Richard T. Silver

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 507 KB
Volume: 55
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19850515)55:10<2342::aid-cncr2820551008>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma

✍ Leroy M. Parker; C. Thomas Griffiths; Ronald A. Yankee; George P. Canellos; Rebe 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 585 KB

Combination chemotherapy with Adriamycin-cyclophosphamide was employed after surgical treatment in 60 women with Stage 111-IV ovarian adenocarcinoma. Of 53 evaluable patients, objective response was noted in 34 of 41 (83%) without prior cytotoxic therapy but in only two of 12 (17%) who had failed a

Randomized trial of the addition of cis-

Randomized trial of the addition of cis-platin (DDP) and/or BCG to cyclophosphamide (CTX) chemotherapy for ovarian carcinoma

✍ Dr. David W. Wilbur; Robert E. Rentschler; Robert J. Wagner; Elden D. Keeney; Al 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Combined chemotherapy with cyclophospham

Combined chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP

✍ Clara D. Bloomfield; Raymond B. Weiss; Ignacio Fortuny; Gerald Vosika; B. J. Ken 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

Alternating noncross-resistant combinati

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma

✍ G. R. Blumenschein; G. N. Hortobagyi; S. P. Richman; J. U. Gutterman; C. K. Tash 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 653 KB

One hundred fifty-six evaluable patients with metastatic breast cancer were treated with vincristine, Adriamycin and cyclophosphamide alternating a t fixed intervals with 5-FU and methotrexate. Immunotherapy with BCG or MER-BCG was administered to all patients in two consecutive treatment programs.

Chemotherapy rapidly alternating with ac

Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: A feasibility study

✍ Dr. Bhadrasain Vikram; Dr. Stephen Malamud; Dr. Jay Gold; Dr. Moses Nussbaum; Dr 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB

## Abstract Patients with advanced carcinomas of the hypopharynx or upper esophagus have among the worst prognoses in head and neck oncology. We developed a treatment regimen of rapidly alternating multi‐agent chemotherapy and accelerated interrupted radiotherapy as follows: Three cycles of chemoth

Adriamycin, dibromodulcitol, and mitomyc

Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone

✍ Kavitha Pinnamaneni; Hwee-Yong Yap; Aman U. Buzdar; Alfred Distefano; George R. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views